<result><Target><Item><Target_ID> 601</Target_ID>
<Target_Name>Anti-CA monoclonal antibody A-56.36</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 602</Target_ID>
<Target_Name>Anti-Myohemerythrin monoclonal antibody A2</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>This monoclonal antibody was generated against the MHr peptide fragment EVVPHKKMHKDFLEKIGGL(69-87), binding to myohemerythrin strongly with a dissociation constants of 50nM.</Comments>
</Item><Item><Target_ID> 603</Target_ID>
<Target_Name>Anti-Myohemerythrin monoclonal antibody M33</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>This monoclonal antibody was generated against the myohemerythrin (MHr) pprotein, binding to MHr with a dissociation constants of 640nM.</Comments>
</Item><Item><Target_ID> 604</Target_ID>
<Target_Name>Chronic Lymphocytic Leukemia Fragment Antigen-Binding (Fab) Fragments Fab001</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>BCRs from 8 randomly chosen patients with CLL were expressed as Fab fragments, termed &quot;Fab&quot; followed by a patient-specific number.</Comments>
</Item><Item><Target_ID> 605</Target_ID>
<Target_Name>Chronic Lymphocytic Leukemia Fragment Antigen-Binding (Fab) Fragments Fab003</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>BCRs from 8 randomly chosen patients with CLL were expressed as Fab fragments, termed &quot;Fab&quot; followed by a patient-specific number.</Comments>
</Item><Item><Target_ID> 606</Target_ID>
<Target_Name>Chronic Lymphocytic Leukemia Fragment Antigen-Binding (Fab) Fragments Fab004</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>BCRs from 8 randomly chosen patients with CLL were expressed as Fab fragments, termed &quot;Fab&quot; followed by a patient-specific number.</Comments>
</Item><Item><Target_ID> 607</Target_ID>
<Target_Name>Chronic Lymphocytic Leukemia Fragment Antigen-Binding (Fab) Fragments Fab005</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>BCRs from 8 randomly chosen patients with CLL were expressed as Fab fragments, termed &quot;Fab&quot; followed by a patient-specific number.</Comments>
</Item><Item><Target_ID> 608</Target_ID>
<Target_Name>Chronic Lymphocytic Leukemia Fragment Antigen-Binding (Fab) Fragments Fab006</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>BCRs from 8 randomly chosen patients with CLL were expressed as Fab fragments, termed &quot;Fab&quot; followed by a patient-specific number.</Comments>
</Item><Item><Target_ID> 609</Target_ID>
<Target_Name>Chronic Lymphocytic Leukemia Fragment Antigen-Binding (Fab) Fragments Fab007</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>BCRs from 8 randomly chosen patients with CLL were expressed as Fab fragments, termed &quot;Fab&quot; followed by a patient-specific number.</Comments>
</Item><Item><Target_ID> 610</Target_ID>
<Target_Name>Tyrosine-protein kinase Yes</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P09324</Target_Sequence>
<Synonyms>p61-Yes
EC=2.7.10.2</Synonyms>
<Target_Source>Gallus gallus (Chicken):9031</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 611</Target_ID>
<Target_Name>Anti-HIV-l isotype MN gp120 monoclonal antibody 58.2</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:4558278, GI:4558277</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 612</Target_ID>
<Target_Name>Anti-ovarian carcinoma monoclonal antibody OV-TL3</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:693814, GI:693815</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>OV-TL3, raised after immunization with an extract of an endometrioid cancer biopsy, has a reactivity pattern highly restricted to ovarian carcinomas and was shown to react with a surface glycoprotein by molecular cloning of the antigen. Isotype: IgG1, kappa.</Comments>
</Item><Item><Target_ID> 613</Target_ID>
<Target_Name>Anti-ovarian carcinoma monoclonal antibody OV-TL16</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:693816, GI:693817</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>OV-TL16 was raised after immunization with cyst fluid obtained from a poorly differentiated ovarian carcinoma. Isotype: IgG1, kappa.</Comments>
</Item><Item><Target_ID> 614</Target_ID>
<Target_Name>Anti-proenkephalin monoclonal antibody PE1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:1363160</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The antibody was raised against human proenkephalin-beta-galactosidase fusion protein synthesized in Escherichia coli.</Comments>
</Item><Item><Target_ID> 615</Target_ID>
<Target_Name>Anti-proenkephalin monoclonal antibody PE2</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:1363159</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The antibody was raised against human proenkephalin-beta-galactosidase fusion protein synthesized in Escherichia coli.</Comments>
</Item><Item><Target_ID> 616</Target_ID>
<Target_Name>Anti-proenkephalin monoclonal antibody PE13</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:1363153</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The antibody was raised against human proenkephalin-beta-galactosidase fusion protein synthesized in Escherichia coli.</Comments>
</Item><Item><Target_ID> 617</Target_ID>
<Target_Name>Anti-proenkephalin monoclonal antibody PE14</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:854291</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The antibody was raised against human proenkephalin-beta-galactosidase fusion protein synthesized in Escherichia coli.</Comments>
</Item><Item><Target_ID> 618</Target_ID>
<Target_Name>Anti-proenkephalin monoclonal antibody PE15</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:1363160</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The antibody was raised against human proenkephalin-beta-galactosidase fusion protein synthesized in Escherichia coli.</Comments>
</Item><Item><Target_ID> 619</Target_ID>
<Target_Name>Anti-proenkephalin monoclonal antibody PE19</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:1363164</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The antibody was raised against human proenkephalin-beta-galactosidase fusion protein synthesized in Escherichia coli.</Comments>
</Item><Item><Target_ID> 620</Target_ID>
<Target_Name>Anti-proenkephalin monoclonal antibody PE20</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:1363166</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The antibody was raised against human proenkephalin-beta-galactosidase fusion protein synthesized in Escherichia coli.</Comments>
</Item><Item><Target_ID> 621</Target_ID>
<Target_Name>Anti-proenkephalin monoclonal antibody PE21</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:1363167</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The antibody was raised against human proenkephalin-beta-galactosidase fusion protein synthesized in Escherichia coli.</Comments>
</Item><Item><Target_ID> 622</Target_ID>
<Target_Name>Anti-proenkephalin monoclonal antibody PE22</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:1363168</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The antibody was raised against human proenkephalin-beta-galactosidase fusion protein synthesized in Escherichia coli.</Comments>
</Item><Item><Target_ID> 623</Target_ID>
<Target_Name>Anti-proenkephalin monoclonal antibody PE23</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:1363169</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The antibody was raised against human proenkephalin-beta-galactosidase fusion protein synthesized in Escherichia coli.</Comments>
</Item><Item><Target_ID> 624</Target_ID>
<Target_Name>Anti-proenkephalin monoclonal antibody PE24</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:1363170</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The antibody was raised against human proenkephalin-beta-galactosidase fusion protein synthesized in Escherichia coli.</Comments>
</Item><Item><Target_ID> 625</Target_ID>
<Target_Name>Anti-proenkephalin monoclonal antibody PE25</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence>GI:1363171</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The antibody was raised against human proenkephalin-beta-galactosidase fusion protein synthesized in Escherichia coli.</Comments>
</Item></Target></result>